MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
MEG as a platform for clinical trials. From understanding dementia to supporting experimental medicine.

MEG as a platform for clinical trials. From understanding dementia to supporting experimental medicine.

by Naomi Devlin | Aug 15, 2025 | Masterclass - Translational Research

MEGIN Masterclass MEG as a platform for clinical trials. From understanding dementia to supporting experimental medicine. Presented by Dr Laura Hughes, Research Associate at the University of Cambridge Abstract: “Magnetoencephalography (MEG) is a promising...
MEG to gain insight into Parkinson’s disease and its treatment

MEG to gain insight into Parkinson’s disease and its treatment

by Naomi Devlin | Jun 19, 2025 | Masterclass - Translational Research

MEGIN Masterclass MEG to gain insight into Parkinson’s disease and its treatment Presented by Esther Florin, Lichtenburg Professor for Systems Neuroscience. Abstract: “Deep Brain Stimulation (DBS) is an invasive treatment option for neurological and psychiatric...
Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk

Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk

by Naomi Devlin | Jun 6, 2025 | Masterclass - Translational Research

MEGIN Masterclass Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk Presented by Hanna Renvall (PhD) – Assistant Professor Dept. Neuroscience and Biomedical Engineering, Scientific Director of...
MEG in Translational Neuroscience: Present and Future Applications

MEG in Translational Neuroscience: Present and Future Applications

by MEGIN | Sep 4, 2024 | Masterclass - Translational Research

MEGIN Masterclass MEG in Translational Neuroscience: Present and Future Applications Presented by Professor Peter Uhlhaas. Abstract: “Magnetoencephalography (MEG) provides noninvasive measurements of fluctuations in the excitability of neuronal populations with...
Multimodal MEG Fusion to Study Neurodegenerative Disorders

Multimodal MEG Fusion to Study Neurodegenerative Disorders

by MEGIN | Dec 14, 2023 | Masterclass - Translational Research

MEGIN Masterclass Multimodal MEG Fusion to Study Neurodegenerative Disorders Presented by Alex Wiesman, PhD. Abstract: “This Masterclass is presented by Alex Wiesman, postdoctoral fellow at the Montreal Neurological Institute. The webinar will discuss,...
Novel Markers of the Epileptic Network in MEG

Novel Markers of the Epileptic Network in MEG

by MEGIN | Sep 28, 2023 | Masterclass - Translational Research

MEGIN Masterclass Novel Markers of the Epileptic Network in MEG Presented by Dr. Stefan Rampp. Abstract: “In recent years, a range of novel MEG markers have been identified, which may be applied for focus localization for epilepsy surgery. Ranging from...

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.